| Catalog No. | HT343036 |
|---|
| Species reactivity | Human |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Host species | Humanized |
|---|
| Isotype | IgG1-kappa |
|---|
| Expression system | Mammalian Cells |
|---|
| Clonality | Monoclonal |
|---|
| Target | GDF-8, GDF8, MSTN, Myostatin, Growth/differentiation factor 8 |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G purified from cell culture supernatant. |
|---|
| Accession | O14793 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS, pH 7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| Alternate Names | PF-06252616, 1629605-31-7 |
|---|
| Background | Ramatercept (ACE-031) is a soluble ActRIIB receptor and can be used as a soluble activin receptor 2 (ACVR2) antagonist. Ramatercept inhibits the signal pathway of muscle growth inhibition and has potential application in muscle atrophy.
• Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction., PMID:33938454
• Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member., PMID:9139826
• GDF8 inhibition enhances musculoskeletal recovery and mitigates posttraumatic osteoarthritis following joint injury., PMID:38019905
• Growth differentiation factor 8 down-regulates pentraxin 3 in human granulosa cells., PMID:25641196
• Growth differentiation factor myostatin regulates epithelial-mesenchymal transition genes and enhances invasion by increasing serine protease inhibitors E1 and E2 in human trophoblast cells., PMID:37738042
• Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation., PMID:27481097
• Circulating Growth Differentiation Factor 11/8 Levels Decline With Age., PMID:26489925
• Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11., PMID:30814254
• Effects of growth differentiation factor 8 on steroidogenesis in human granulosa-lutein cells., PMID:26607022
• Molecular characterization of latent GDF8 reveals mechanisms of activation., PMID:29348202
|
|---|
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|---|
